The Pacific Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (PSW RCE) was funded in May, 2005 by the National Institute of Allergies and Infectious Diseases (NIAID). The PSW RCE serves Region IX and is one of ten nationally funded Centers which support the NIAID Biodefense and Emerging Infectious Diseases Research Agenda.
The overall goals for the PSW RCE are:
– To produce outstanding multi-disciplinary and collaborative research on selected infectious diseases.
– To disseminate research findings and reagents within the RCE network and to local, state, and federal agencies.
– To timely translate findings into products and applications to detect, monitor, prevent, and treat these infections.
– To provide opportunities for new investigators to enter the field and develop innovative training programs to enhance biodefense readiness.
– To respond to bioterrorism threats and emerging infectious disease emergencies by providing local, state, and federal agencies with on-call preparedness.
The Center will achieve these goals through a coordinated effort of research teams located at several public and private institutions across the Region, which encompasses the states of California, Arizona, Nevada and Hawaii.
This organization is recognized as one of the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases (RCEs) by the National Institute of Allergy and Infectious Diseases (NIAID).
- Website:
- http://www.pswrce.uci.edu/
- Phone:
- (949) 824-0251
- Address:
- University of California - Irvine | 3056 Hewitt Hall | Irvine, CA 92697-4028
- April 25, 2011
- | Filed under North America, Academia, and Other
- Share
The Partnership for Global Security (PGS), originally incorporated as the Russian American Nuclear Security Advisory Council, seeks “to create the broad and integrated networks of private and public partnerships that are necessary to meet the 21st century’s global security challenges. PGS’ goal is to prevent foreseeable weapon of mass destruction threats from becoming a reality by complementing and supplementing the work of governments and achieving tangible results.” The Biological Threat Reduction Project “focuses on reducing the potential for the proliferation of dangerous biological agents by promoting security for sensitive biological infrastructure, monitoring bilateral and multilateral efforts to create peaceful market-oriented and public health-related employment opportunities for biological experts in Russia and the former Soviet states, and developing new initiatives that can facilitate these goals.”
- Website:
- http://www.partnershipforglobalsecurity.org/Projects/Biologi...
- Phone:
- (202) 332-1412
- Address:
- 1025 Connecticut Avenue NW Suite 1106, Washington, DC 20036 USA
- July 8, 2010
- | Filed under North America and NGO
- Share
Department of Biotechnology
- Website:
- http://www.bio.pku.edu.cn/english/
- Phone:
- +86 10 6275 7627
+ 86 10 6275 1218
- July 15, 2010
- | Filed under Asia/Pacific and Academia
- Share
Pfizer is a global pharmaceutical company that discovers, develops and manufactures medicines for people and animals. Pfizer was they first company to manufacture penicillin, and continues to develope new antibiotics and infectious disease vaccines and treatments.
- Website:
- http://www.pfizer.com/home/
- Phone:
- + 1 (212) 733 - 2323
- Address:
- 235 East 42nd Street | NYC, NY 10017 USA
- August 6, 2010
- | Filed under North America and Industry
- Share
PIF is an association supervising the industrial policy interests of the research-based pharmaceutical industry. PIF’s aim is to develop the competitiveness as well as the research and operation environment of the industry both in Finland and the EU so that the best possible pharmaceutical treatment reaches patients without delays. This is done by influencing economic, industry and socio-policy legislation.
- Website:
- http://www.pif.fi/page.php?page_id=114%20
- Phone:
- +358 9 6150 4900
- Address:
- Porkkalankatu 1, P.O. Box 206, 00181 Helsinki, Finland
- July 27, 2010
- | Filed under Europe and Industry
- Share